Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems. The company also provides OmniLinkRx, a prescription routing system; WorkflowRx, an automated pharmacy storage, retrieval, and packaging system; Central and Satellite Pharmacy Manager, an automated pharmacy storage and retrieval system; Controlled Substance Management, a controlled substance inventory management system; and Anesthesia Workstation that manages anesthesia supplies and medications. In addition, it offers Omnicell Supply Management System, which automates the management and dispensing of medical and surgical supplies; Omnicell Tissue Center, which manages the chain of custody for bone and tissue specimens; OptiFlex MS that manages medical and surgical supplies; OptiFlex SS, a module for the perioperative areas; OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas. Further, Omnicell, Inc. offers Mach4 Pharma Systems Medimat, a robotic dispensing system for handling the stocking and retrieval of medications; IV Solutions; software; and consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.

The investment seeks to provide investors with exposure to the Barclays Sugar Pure Beta Total Return Index. The Barclays Sugar Pure Beta Total Return Index (the "index") reflects the returns that are potentially available through an unleveraged investment in the futures contracts in the Sugar markets. The index may roll into one of a number of futures contracts with varying expiration dates, as selected using the Barclays Pure Beta Series 2 Methodology.

America's Car-Mart, Inc., through its subsidiaries, operates as an automotive retailer in the United States. The company primarily sells older model used vehicles and provides financing for its customers. As of April 30, 2017, it operated 140 dealerships in 11 states in the South-Central United States. America's Car-Mart, Inc. was founded in 1981 and is headquartered in Bentonville, Arkansas.